Masayo Nagai-Shamoto

Nisshin, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Phytochemicals Modulate Biosynthesis and Function of Serotonin, Dopamine, and Norepinephrine for Treatment of Monoamine Neurotransmission-Related Psychiatric Diseases.

Phytochemicals Modulate Biosynthesis and Function of Serotonin, Dopamine, and Norepinephrine for Treatment of Monoamine Neurotransmission-Related Psychiatric Diseases.

Journal: International journal of molecular sciences

Published: January 12, 2025

Type A monoamine oxidase; its unique role in mood, behavior and neurodegeneration.

Type A monoamine oxidase; its unique role in mood, behavior and neurodegeneration.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: October 02, 2024

Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson's disease.

Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson's disease.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: October 15, 2023

Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies.

Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies.

Journal: International journal of molecular sciences

Published: August 23, 2022

Disease-modifying treatment of Parkinson's disease by phytochemicals: targeting multiple pathogenic factors.

Disease-modifying treatment of Parkinson's disease by phytochemicals: targeting multiple pathogenic factors.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: September 14, 2021

Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson's disease.

Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson's disease.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: December 12, 2019

Mitochondria in Neuroprotection by Phytochemicals: Bioactive Polyphenols Modulate Mitochondrial Apoptosis System, Function and Structure.

Mitochondria in Neuroprotection by Phytochemicals: Bioactive Polyphenols Modulate Mitochondrial Apoptosis System, Function and Structure.

Journal: International journal of molecular sciences

Published: April 20, 2019

Modification of α-synuclein by lipid peroxidation products derived from polyunsaturated fatty acids promotes toxic oligomerization: its relevance to Parkinson disease.

Modification of α-synuclein by lipid peroxidation products derived from polyunsaturated fatty acids promotes toxic oligomerization: its relevance to Parkinson disease.

Journal: Journal of clinical biochemistry and nutrition

Published: February 16, 2018

Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons.

Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: November 15, 2017

Neurotrophic function of phytochemicals for neuroprotection in aging and neurodegenerative disorders: modulation of intracellular signaling and gene expression.

Neurotrophic function of phytochemicals for neuroprotection in aging and neurodegenerative disorders: modulation of intracellular signaling and gene expression.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: August 08, 2017

Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline.

Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: March 29, 2017

Type A monoamine oxidase and serotonin are coordinately involved in depressive disorders: from neurotransmitter imbalance to impaired neurogenesis.

Type A monoamine oxidase and serotonin are coordinately involved in depressive disorders: from neurotransmitter imbalance to impaired neurogenesis.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: January 16, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026